Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6 Lymphoid 4 Thoracic 1 Plasma cell 1 Gastrointestinal 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 70 Cyclophosphamide 44 Bortezomib 41 Lenalidomide 25 Melphalan 24 Thalidomide 19 pomalidomide 17 daratumumab 14 fludarabine 13 carfilzomib 10 Filgrastim 8 Doxorubicin 8 Busulfan 6 isatuximab 5 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Calcium Dobesilate 5 Bendamustine Hydrochloride 5 selinexor 4 sargramostim 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Etoposide 4 Clarithromycin 4 liposomal doxorubicin 3 ixazomib 3 dexamethasone acetate 3 Radiotherapy 3 Neoadjuvant Therapy 3 Mycophenolic Acid 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sensitivity and Specificity × Plasma cell × Clear all

NCT01886976 2016-01-28

CART-138

Chinese PLA General Hospital

Phase 1/2 Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡